Recent Acquisition Impact The acquisition of Cerus Endovascular by Stryker suggests a significant strategic move, potentially expanding Stryker's portfolio in neurointerventional devices and creating cross-selling opportunities for complementary product lines.
Innovative Product Launch With FDA 510(k) clearance secured for its microcatheters, Cerus Endovascular is positioned to accelerate its market entry and distribution, offering a compelling proposition for sales partners focused on neurovascular treatments.
Growth Funding & Potential Having raised $19 million in Series B funding, Cerus Endovascular demonstrates investor confidence which could translate into increased resources for research, development, and expanding its sales footprint.
Market Specialization Focused on highly differentiated neurointerventional devices for intracranial aneurysms, Cerus Endovascular presents a niche opportunity for companies targeting the neurovascular segment with advanced minimally invasive solutions.
Technology Adoption Utilizing advanced web and development tools such as React and RequireJS, Cerus Endovascular indicates a modern approach to digital engagement, facilitating potential sales outreach and customer education through its online platforms.
$1B$10B
$1M$10M
$10M$25M
$10B
$250M$500M
$10M$25M
$10B
$10BCerus Endovascular uses 7 technology products and services including Webpack, DreamWeaver, Google Fonts API, and more. Explore Cerus Endovascular's tech stack below.
| Cerus Endovascular Email Formats | Percentage |
| First.Last@cerusendo.com | 50% |
| First.Last@cerusendo.com | 50% |
Medical Equipment ManufacturingEngland, United Kingdom11-50 Employees
Cerus Endovascular is engaged in the design and development of highly differentiated and proprietary interventional neuroradiology (INR) devices and delivery systems. Cerus believes that these devices represent the next generation in the minimally invasive treatment of neurovascular diseases, particularly intracranial aneurysms.
Company Overview
Funding & FinancialsCerus Endovascular has raised a total of $19M of funding over 1 rounds. .
Cerus Endovascular's revenue is estimated to be in the range of $1M
Funding & FinancialsCerus Endovascular has raised a total of $19M of funding over 1 rounds. .
Cerus Endovascular's revenue is estimated to be in the range of $1M
1-888-653-2347 
support@leadiq.com